A phase 2 study of s-1 plus leucovorin in patients with untreated advanced cholangiocarcinoma (CCA). This is an ASCO Meeting Abstract from the . This abstract does not include a full text component.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results